Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 131.8 USD -0.6% Market Closed
Market Cap: 25B USD

Wall Street
Price Targets

INSM Price Targets Summary
Insmed Inc

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 145.73 USD with a low forecast of 99.99 USD and a high forecast of 252 USD.

Lowest
Price Target
99.99 USD
24% Downside
Average
Price Target
145.73 USD
11% Upside
Highest
Price Target
252 USD
91% Upside
Insmed Inc Competitors:
Price Targets
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
7% Downside
SRZN
Surrozen Inc
233% Upside
SNDX
Syndax Pharmaceuticals Inc
136% Upside
ZNTL
Zentalis Pharmaceuticals Inc
238% Upside
ZEAL
Zealand Pharma A/S
101% Upside
BSLN
Basilea Pharmaceutica AG
90% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
25% Upside
MNKD
MannKind Corp
134% Upside

Revenue
Forecast

Revenue Estimate
Insmed Inc

For the last 13 years the compound annual growth rate for Insmed Inc's revenue is 40%. The projected CAGR for the next 3 years is 74%.

40%
Past Growth
74%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INSM's stock price target?
Price Target
145.73 USD

According to Wall Street analysts, the average 1-year price target for INSM is 145.73 USD with a low forecast of 99.99 USD and a high forecast of 252 USD.

What is Insmed Inc's Revenue forecast?
Projected CAGR
74%

For the last 13 years the compound annual growth rate for Insmed Inc's revenue is 40%. The projected CAGR for the next 3 years is 74%.

Back to Top